From Left to Right: Dr. Larry Librach (CHPCA Board of Directors),
Mr. Paul Lucas (President, The GlaxoSmithKline Foundation),
Ms. Sharon Baxter (Executive Director, CHPCA)
The Canadian Hospice Palliative Care Association (CHPCA) has awarded The GlaxoSmithKline Foundation the 2004 CHPCA Leadership Award in recognition of its outstanding contribution to the field of hospice palliative care in Canada.
The CHPCA Leadership Award is given to an individual or group, in this case The GlaxoSmithKline Foundation, in recognition of their exceptional leadership, dedication and vision in advancing hospice palliative care for all Canadians. The Foundation has helped to achieve significant progress in hospice palliative care by initiating and supporting ground-breaking programs and bringing much needed attention to this issue.
Commitment in Action
GlaxoSmithKline Inc. (GSK) employees chose hospice palliative care as the company’s cause of choice in 1997. Since then, the company has spearheaded a number of initiatives to assist the three million Canadians who care for terminally ill family members.
Living Lessons®, a collaborative effort by The GlaxoSmithKline Foundation and CHPCA, has contributed to a marked growth in public awareness. Living Lessons helps to educate patients, family caregivers, medical professionals, policy makers and the public-at-large about the resources and expertise that are available in their communities and advocates for additional programs and funding. As part of the program, A Guide for Caregivers offers practical advice and a collection of compelling personal stories to support caregivers.
GSK reaffirmed its commitment to the hospice palliative care movement by becoming the first company in Canada to establish an extended leave benefit for employees needing time off from work to care for critically or terminally ill family members.